Miners hauled the ASX higher after soft US inflation calmed rate fears, while Macquarie hit a record.
Resmed might still be the best performer of biotech's Big Four, but some investors aren't sleeping tight after last week's $700 million divestment.
Continued hits of carbonatite extensions signal a potentially bigger REE footprint in Malawi.
Morning Feed plates up early sharemarket movers, announcements and company news, serving investors a quick hit of market action and updates from selected ASX-listed companies.
CEO David Selfe discusses the company's positive update from the Van Uden heap leach study.
